Stay updated with breaking news from Nyse Path. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of UiPath Inc. (NYSE:PATH – Get Rating) have been assigned a consensus recommendation of “Moderate Buy” from the nineteen research firms that are presently covering the stock, MarketBeat Ratings reports. Five equities research analysts have rated the stock with a hold recommendation and eight have issued a buy recommendation on the company. The average […]
Shares of UiPath Inc. (NYSE:PATH – Get Rating) have earned an average rating of “Moderate Buy” from the nineteen brokerages that are covering the stock, MarketBeat.com reports. Five equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. The average twelve-month target price among […]
UiPath (NYSE:PATH – Get Rating) had its price target increased by Royal Bank of Canada from $17.00 to $18.00 in a report released on Wednesday, The Fly reports. They currently have a sector perform rating on the healthcare company’s stock. Several other equities analysts have also recently issued reports on the stock. Truist Financial dropped […]
UiPath (NYSE:PATH – Get Rating) had its price target hoisted by Royal Bank of Canada from $17.00 to $18.00 in a research note published on Wednesday, The Fly reports. They currently have a sector perform rating on the healthcare company’s stock. A number of other analysts have also recently commented on PATH. Credit Suisse Group […]
Bank of New York Mellon Corp grew its holdings in shares of UiPath Inc. (NYSE:PATH – Get Rating) by 22.4% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 1,801,779 shares of the healthcare company’s stock after buying an additional 329,651 shares during the period. Bank […]